KRUUSE PGA Suture, USP 5/EP 7, 15 m/49.2 ft, violet, 1/pk
150702
■ Suitable for subcutaneous and soft tissue surgery e.g. GI, urologic surgery, and orthopedic surgery where a midterm absorption profile is needed
■ USP 5
■ EP 7
■ Casette
■ Suture length: 15 m / 49.2 ft
■ Colour: Violet
■ 1/pk
■ USP 5
■ EP 7
■ Casette
■ Suture length: 15 m / 49.2 ft
■ Colour: Violet
■ 1/pk
KRUUSE PGA Suture is a synthetic, absorbable, multifilament, sterile surgical suture composed of polyglycolic acid and coated with polycaprolactone and calcium stearate.
Available dyed violet.
Complete mass absorption in 60-90 days (approximately 75% of original tensile strength 14 days after implantation, 40% of original tensile strength 21 days after implantation).
Indications
KRUUSE PGA Sutures are indicated for soft tissue approximation and ligation, where absorbable sutures are indicated, including:
■ Blood vessel ligation
■ Ductus ligation
■ Facia approximation
■ Gynaecology and abstretics
■ Joint capsula closure
■ Ligament ligation
Contraindications
KRUUSE PGA Suture is not intended for use in cardiovascular tissue, neurosurgery, or ophthalmic surgery.
Range in peel pack
USP 4-0 to 6
EP 1.5 to 8
Range in casettes
USP 3-0 to 6
EP 2 to 8
Sterilisation method: EO
Available dyed violet.
Complete mass absorption in 60-90 days (approximately 75% of original tensile strength 14 days after implantation, 40% of original tensile strength 21 days after implantation).
Indications
KRUUSE PGA Sutures are indicated for soft tissue approximation and ligation, where absorbable sutures are indicated, including:
■ Blood vessel ligation
■ Ductus ligation
■ Facia approximation
■ Gynaecology and abstretics
■ Joint capsula closure
■ Ligament ligation
Contraindications
KRUUSE PGA Suture is not intended for use in cardiovascular tissue, neurosurgery, or ophthalmic surgery.
Range in peel pack
USP 4-0 to 6
EP 1.5 to 8
Range in casettes
USP 3-0 to 6
EP 2 to 8
Sterilisation method: EO
| Weight including packaging in kg | 0,25 |
| Barcode | 5703188349101 |